Κατάθλιψη: Διαφορά μεταξύ των αναθεωρήσεων
Περιεχόμενο που διαγράφηκε Περιεχόμενο που προστέθηκε
Χωρίς σύνοψη επεξεργασίας |
Yobot (συζήτηση | συνεισφορές) μ →Βιταμίνες - Μέταλλα - Ιχνοστοιχεία - Αμινοξέα: Διόρθωση συντακτικού κώδικα με τη χρήση AWB (10458) |
||
Γραμμή 209:
<ref>Erdmann, Robert & Jones, Meirion. The Amino Revolution. Century Hutchinson. London, United Kingdom. 1987:57.</ref>
<ref>The Directory of Life Extension Supplements. Life Extension Media, Florida, USA. 2000:45.</ref>,Phenylalanine
<ref name="HTP 1999"/>▼
<ref>Beckman, H. Phenylalanine in affective disorders. Adv Biol Psychiat. 10:137-147, 1983.</ref>
<ref>Beckmann, H., et al. Dl-phenylalanine in depressed patients: an open study. J Neural Transm. 41(2-3):123-134, 1977.</ref>
<ref>Beckmann, H., et al. DL-phenylalanine versus imipramine: a double-blind controlled study. Arch Psychiatr Nervenkr. 227(1):49-58, 1979.</ref>
<ref>Kravitz, H. M., et al. Dietary supplements of phenylalanine and other amino acid precursors of brain neuroamines in the treatment of depressive disorders. J Am Osteopath Assoc. 84(1 Supplement):119-123, 1984.</ref>
▲<ref name="HTP 1999"/>
<ref>Sabelli, H. C., et al. Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements. J Clin Psychiatr. 47:66-70, 1986.</ref>
<ref>Heller, B. Pharmacological and clinical effects of DL-phenylalanine in depression and Parkinson’s disease. In: Modern Pharmacology-toxicology, Noncatecholic Phenylethylamines, Part 1. Mosnaim, A. D. and Wolfe, M. E., editors. Marcel Dekker, New York, USA. 1978:397-417.</ref>
Γραμμή 341:
<ref name="Whittaker, J 1999">Whittaker, J. How to lift depression safely. Health & Healing. 9(9):4-7, 1999.</ref>
<ref>Folic acid: multi-function essential vitamin. LifeLink Product Catalog. 2001:13.</ref>,Ινοσιτόλη
<ref>Barkai, A. I., et al. Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder. Biol Psych. 13(1):65-72, 1978.</ref>▼
<ref name="Badash, M 1998"/>
▲<ref>Barkai, A. I., et al. Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder. Biol Psych. 13(1):65-72, 1978.</ref>
<ref>Benjamin, J. et al. Inositol treatment in psychiatry. Psychopharmacol Bull. 31:167-175, 1995.</ref>
<ref>Colodny, L., et al. Inositol - clinical applications for exogenous use. Alternative Medicine Review. 3(6):432-447, 1998.</ref>
Γραμμή 373:
<ref>Segala, M. (editor). Disease Prevention and Treatment 3rd Edition. Life Extension Media. Florida, USA. 2000:227.</ref>,
η Βιταμίνη B6
<ref name="Whittaker, J 1999"/>▼
<ref name="Carney, M. W. 1982"/>
<ref>Carney, M. W., et al. Thiamine, and pyridoxine lack in newly-admitted psychiatric patients. British Journal of Psychiatry. 135:249-254, 1979.</ref>
<ref>Hawkins, W. W., et al. An experiment on human vitamin B6 deprivation. Science. 108:284-286, 1948.</ref>
▲<ref name="Whittaker, J 1999"/>
<ref>Hvas, A. M., et al. Vitamin b(6) level is associated with symptoms of depression. Psychother Psychosom. 73(6):340-343, 2004.</ref>
<ref>McCarty, M. F. High-dose pyridoxine as an 'anti-stress' strategy. Med Hypotheses. 54(5):803-807, 2000.</ref>
| |||